This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
4F-MPH: Difference between revisions
>Kenan |
>Mt flyer05 Clarified the MOA and added comparative DRI potency |
||
| Line 18: | Line 18: | ||
==Pharmacology== | ==Pharmacology== | ||
{{Stub}} | {{Stub}} | ||
4F-MPH is thought to act primarily as a [[dopamine]] [[reuptake inhibitor]], meaning it effectively boosts the levels of dopamine [[neurotransmitters]] in the brain by binding to and partially blocking the transporter proteins that normally clear these | 4F-MPH is thought to act primarily as a [[dopamine and norepinephrine]] [[reuptake inhibitor]], meaning it effectively boosts the levels of dopamine and norepinephrine [[neurotransmitters]] in the brain by binding to and partially blocking the transporter proteins that normally clear these catecholamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the reward pathways in the brain, resulting in stimulating and euphoric effects. According to a recent study, 4-FMPH is about as effective as methylphenidate as a norepinephrine reuptake inhibitor (NRI), but is approximately three times as effective at inhibiting the reuptake of dopamine as its parent compound. | ||
==Subjective effects== | ==Subjective effects== | ||